Aggressive Stocks Based on Big Data Analytics : Returns up to 27.57% in 7 Days

Aggressive Stocks

This forecast is part of the Risk-Conscious Package, as one of I Know First’s equity research solutions. We determine our aggressive stock picks by screening our algorithm daily for higher volatility stocks that present greater opportunities but are also riskier. The full Risk-Conscious Package includes a daily forecast for a total of 40 stocks divided into four main categories:

  • Top 10 Aggressive stocks for the long position
  • Top 10 Aggressive stocks for the short position
  • Top 10 Conservative stocks for the long position
  • Top 10 Conservative stocks for the short position


Package Name: Risk-Conscious – Aggressive Stocks Forecast
Recommended Positions: Long
Forecast Length: 7 Days (05/29/2018 – 06/05/2018)
I Know First Average: 7.85%
Aggressive Stocks

Several predictions in this short-term 7 Days forecast saw significant returns. The algorithm had correctly predicted 8 out 10 stock movements. AVXL was the top performing prediction with a return of 27.57%. ASNA and ENT saw outstanding returns of 24.21% and 18.59%. With these notable trade returns, the package itself registered an average return of 7.85% compared to the S&P 500’s return of 1.01% for the same period.

Anavex Life Sciences Corp., incorporated on January 23, 2004, is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including drug candidates to treat Alzheimer’s disease (AD), other central nervous system (CNS) diseases, pain and various types of cancer. Its research and development pipeline includes a clinical drug candidate and various compounds in different stages of pre-clinical study. Its product pipeline also includes ANAVEX 2-73, ANAVEX 3-71, ANAVEX 1-41, ANAVEX 1037 and ANAVEX 1066. The Company’s SIGMACEPTOR Discovery Platform produces small molecule drug candidates with modes of action, based on its understanding of sigma receptors. As of September 30, 2016, the Company had not generated any revenues from its operations.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.